Ovais Wadoo
Biographic Data
| ID | 7968253 |
|---|---|
| NAME | Ovais Wadoo |
| GIVEN NAMES | Ovais |
| FAMILY NAME | Wadoo |
| SIGNATURE | WADOO O |
| AFFILIATIONS | Qatar University |
| ORCID | 0000-0001-5023-9245 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Covid-19 disease outcomes in patients receiving clozapine versus other antipsychotics: A national study in Qatar
Clozapine use was not associated with worse COVID-19 outcomes, supporting its relative safety during SARS-CoV-2 infection. These findings reassure clinicians regarding clozapine's continued use in treatment-resistant schizophrenia. However, the small clozapine sample size limits statistical power, warranting cautious interpretation and further research
The Impact of Covid-19 Pandemic on Individuals With Pre-existing Obsessive-Compulsive Disorder in the State of Qatar: An Exploratory Cross-Sectional Study
Adults with pre-existing OCD with fear of contamination reported a statistically significant increase in severity of obsessive-compulsive symptoms only if the duration of their OCD diagnosis was relatively shorter (<10 years). In the context of the conflicting evidence regarding the worsening of OCD symptoms due to the unique infection control measures of this pandemic, this study highlights the importance of the impact of the duration of the dis…
No prominent works on this page.
The Impact of Covid-19 Pandemic on Individuals With Pre-existing Obsessive-Compulsive Disorder in the State of Qatar: An Exploratory Cross-Sectional Study
Adults with pre-existing OCD with fear of contamination reported a statistically significant increase in severity of obsessive-compulsive symptoms only if the duration of their OCD diagnosis was relatively shorter (<10 years). In the context of the conflicting evidence regarding the worsening of OCD symptoms due to the unique infection control measures of this pandemic, this study highlights the importance of the impact of the duration of the dis…
Covid-19 disease outcomes in patients receiving clozapine versus other antipsychotics: A national study in Qatar
Clozapine use was not associated with worse COVID-19 outcomes, supporting its relative safety during SARS-CoV-2 infection. These findings reassure clinicians regarding clozapine's continued use in treatment-resistant schizophrenia. However, the small clozapine sample size limits statistical power, warranting cautious interpretation and further research
Internal Medicine (2 works) · Medicine (2 works) · Psychiatry (2 works) · Anxiety (1 works) · Anxiety disorder (1 works) · Body Image and Dysmorphia Studies (1 works) · Clinical Psychology (1 works) · Clinical Psychology (1 works) · Clozapine (1 works) · Confounding (1 works)